- Home
- SNY vs RXO Comparison
SNY vs RXO Comparison
Compare SNY & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | RXO |
|---|---|---|
| Founded | 1994 | 2022 |
| Country | France | United States |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3B | 2.2B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | SNY | RXO |
|---|---|---|
| Price | $46.78 | $13.78 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 15 |
| Target Price | ★ $58.00 | $16.38 |
| AVG Volume (30 Days) | ★ 3.5M | 1.7M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,742,000,000.00 |
| Revenue This Year | $3.01 | $0.78 |
| Revenue Next Year | $5.80 | $6.58 |
| P/E Ratio | $6.14 | ★ N/A |
| Revenue Growth | N/A | ★ 26.20 |
| 52 Week Low | $43.32 | $10.43 |
| 52 Week High | $55.77 | $19.65 |
Technical Indicators
Market Signals| Indicator | SNY | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 58.16 | 48.21 |
| Support Level | $45.20 | $12.01 |
| Resistance Level | $48.97 | $17.57 |
| Average True Range (ATR) | 0.74 | 0.79 |
| MACD | 0.39 | 0.14 |
| Stochastic Oscillator | 76.16 | 66.87 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.